Facsaria illu 4-laser system service agreement

Ended Awarded Last action

Contract number
75F40120F80506
Awardee
Awarding agency
Obligated
$76,834

Award facts

Opportunity
Contract value 100% obligated
$76,833.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Jefferson, AR 72079, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$51,222
Other Administrative Action P00006 $0
Exercise an Option P00005 $25,611
Exercise an Option P00004 $25,611
Other Administrative Action P00003 · FDA electronic invoicing and payment requirements - invoice processing platform (IPP) $0
Exercise an Option P00002 $25,611
Exercise an Option P00001 $25,611
Original award $25,611

About this award

Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, was awarded a delivery order for a FACSARIA Illumina 4-Laser System Service Agreement by the Food and Drug Administration on September 9, 2020. This firm fixed-price contract, valued at $76.8K with an ultimate completion date of September 22, 2025, represents a child contract under BD's parent company framework. The contract involves the supply and servicing of specialized flow cytometry equipment at the performance location in Jefferson, Arkansas. No small business set-aside designation was applied to this award, reflecting open competition in the federal marketplace. This delivery order falls under BD's broader federal contracting portfolio, which demonstrates the company's significant positioning within government healthcare and research procurement.

BD Biosciences specializes in sophisticated scientific instruments and reagents for flow cytometry, cell imaging, and genomics applications, with extensive experience servicing federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Defense. The FACSARIA system represents advanced biomedical research instrumentation commonly utilized in federal research institutions for cellular analysis applications. BD maintains multiple indefinite delivery vehicles with federal agencies, including blanket purchase agreements and single-award contracts valued in the millions of dollars, establishing the company's strategic role in supporting government healthcare and research initiatives through flexible, long-term procurement relationships.

Quick answers

Who was awarded contract 75F40120F80506?

75F40120F80506 was awarded to Becton, Dickinson And Company by Food and Drug Administration (Department of Health and Human Services) on September 9, 2020.

How much is contract 75F40120F80506 worth?

The government has obligated $76,834 on 75F40120F80506.

Is contract 75F40120F80506 an order under another contract?

Yes. 75F40120F80506 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40120F80506 competed?

The extent of competition for 75F40120F80506 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award